Cetera Investment Advisers Purchases 4,775 Shares of Semler Scientific Inc. (NASDAQ:SMLR)

Cetera Investment Advisers raised its position in Semler Scientific Inc. (NASDAQ:SMLR) by 26.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,654 shares of the company’s stock after purchasing an additional 4,775 shares during the period. Cetera Investment Advisers owned 0.24% of Semler Scientific worth $820,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Interchange Capital Partners LLC bought a new stake in Semler Scientific during the first quarter worth about $46,502,000. Capital International Investors bought a new stake in Semler Scientific in the 4th quarter worth approximately $30,813,000. Susquehanna Advisors Group Inc. purchased a new stake in Semler Scientific in the fourth quarter worth approximately $26,928,000. Driehaus Capital Management LLC bought a new position in Semler Scientific during the fourth quarter valued at approximately $10,122,000. Finally, Geode Capital Management LLC raised its stake in shares of Semler Scientific by 3.3% during the fourth quarter. Geode Capital Management LLC now owns 140,423 shares of the company’s stock worth $7,584,000 after acquiring an additional 4,464 shares in the last quarter. 49.37% of the stock is owned by institutional investors.

Analyst Ratings Changes

SMLR has been the subject of a number of research reports. Wall Street Zen cut shares of Semler Scientific from a “buy” rating to a “sell” rating in a research note on Thursday, May 22nd. Benchmark initiated coverage on shares of Semler Scientific in a research report on Tuesday, July 8th. They set a “buy” rating and a $101.00 price target for the company. Maxim Group upgraded Semler Scientific to a “strong-buy” rating and set a $95.00 price objective on the stock in a report on Wednesday, July 9th. Finally, Cantor Fitzgerald dropped their target price on Semler Scientific from $61.00 to $60.00 and set an “overweight” rating for the company in a report on Wednesday, August 6th. One analyst has rated the stock with a sell rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Semler Scientific currently has an average rating of “Moderate Buy” and a consensus target price of $81.75.

Semler Scientific Stock Performance

NASDAQ:SMLR opened at $35.57 on Thursday. The business has a 50 day moving average price of $37.40 and a 200-day moving average price of $38.85. Semler Scientific Inc. has a fifty-two week low of $21.77 and a fifty-two week high of $81.56. The firm has a market cap of $526.79 million, a PE ratio of 14.64 and a beta of 1.34. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.58 and a current ratio of 0.60.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings data on Monday, August 4th. The company reported $5.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.27) by $5.31. Semler Scientific had a net margin of 86.20% and a return on equity of 43.84%. The firm had revenue of $8.22 million for the quarter, compared to analysts’ expectations of $8.10 million.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.